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Introduction
Cystic ovarian disease (COD) is a common reproduc-
tive disorder in women and females of domestic ani-
mals, leading to temporal or permanent infertility. The
etiology and pathogenesis of COD are still obscured. It
is generally assumed that cysts are mainly caused by
disturbances in the function of the hypothalamic-pitu-
itary-ovarian axis, causing impairment of the synthe-
sis, release, and/or storage of various hormones in this
functional unit. Stressors may, by activation of the
hypothalamic-pituitary-adrenocortical axis, also play
an important role in the formation of ovarian cysts. An
increase in corticotropin-releasing factor secretion
suppresses the activity of hypothalamic gonadotropin-
releasing hormone (GnRH) and luteinizing hormone
(LH). Moreover, studies conducted in pigs and cows
showed that an elevated level of glucocorticoids is able
to inhibit the release of GnRH and/or LH, in this way
changing ovarian steroidogenesis [1-4]. 
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Abstract: In the present study the expression pattern of the cholesterol side-chain cleavage cytochrome (P450scc), 3β-
hydroxysteroid dehydrogenase (3β-HSD) and aromatase (P450arom) was analyzed in the health and polycystic ovaries of
gilts by means of the Western blot and immunohistochemistry. The polycystic status of ovaries was induced by i.m. dexam-
ethasone (DXM) injections on days 7-21 of the estrous cycle. Macroscopic observation of ovaries of DXM-treated gilts
revealed the presence of cysts (1-2 cm in diameter, with a mean number of 7.0±1.2 per ovary), a decrease (P<0.05) in num-
ber of small follicles (1-3 mm in diameter), as well as the lack of medium-sized follicles (4-6 mm in diameter) and corpo-
ra lutea, as compared to the control animals. The expression of P450scc (P<0.01), 3β-HSD (P<0.05) and P450arom (P<0.001)
proteins in the cysts was higher than in the medium-sized follicles of the control gilts. Moreover, DXM injections resulted
also in an enhancement (P<0.05) in the level of P450scc protein in the walls of small follicles as compared to the control
gilts. Following DXM administration the immunoreactivity (IR) of P450scc in the primordial follicles was lower than in the
control group. Comparing to the control gilts, the reaction for this enzyme in DXM-treated animals was observed in sec-
ondary follicles, while for 3β-HSD, in primordial, primary, as well as secondary follicles. The immunostaining for P450scc
(theca cells) and P450arom (granulosa cells) in the small follicles of the DXM-treated gilts were more prominent than those
found in the gonads of control animals. However, IR for P450scc was not found in the granulosa cells of small follicles in
the gilts receiving DXM. The intensity of P450scc and P450arom labelling was distinctly enhanced in the cysts as compared
to the medium follicles of the control animals. Furthermore, in contrary to the medium follicles of the control animals, faint
IR for 3β -HSD was found in the granulosa cell layer of cysts. Our data revealed that both the expression of P450scc, 3β-
HSD and P450arom and localization of these enzymes in polycystic ovaries were different from those, found under physio-
logical conditions. These results suggested that above-mentioned enzymes may, by influencing the ovarian steroid synthe-
sis, play an essential role in the creation and/or course of cystic ovarian disease.
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It has previously been reported that alterations in
the content of steroid hormones in the cystic ovaries of
women [5,6], rat [7] and cow [8] was accompanied by
changes in the expression and cellular distribution pat-
tern of cholesterol side-chain cleavage cytochrome
(P450scc), 3β-hydroxysteroid dehydrogenase (3β-
HSD), 17,20-lyase, 20α-HSD and/or aromatase
cytochrome (P450arom). Furthermore, our pilot study
showed that dexamethasone (DXM) injections in gilts
from day 16 of the first studied estrous cycle until day
9 of the second studied cycle, lead to changes in the of
P450scc, 3β-HSD and P450arom protein expression, as
well as in the content of progesterone (P4), androgens
and estrogens in ovarian structures [9]. It is generally
known that the morphological and functional changes
of polycystic ovaries are closely dependent on the
phase of estrous cycle, in which the administration of
cyst-induced hormones was started [10-12]. Thus, it
may be hypothesized that the beginning of DXM treat-
ment in the luteal phase of the estrous cycle may
induce the changes in the ovarian morphology and
steroidogenic activity, different from those found after
induction of cysts formation during the follicular
phase of the estrous cycle [9]. 
Therefore, the present study was aimed at unravel-
ing in detail (1) the P450scc, 3β-HSD and P450arom pro-
tein expression pattern, and (2) the cellular localization
of P450scc, 3β-HSD and P450arom in the porcine
ovaries with polycystic status, induced by DXM injec-
tions on days 7-21 of the estrous cycle. 
Materials and methods 
Animals and experimental procedure. The experiment was car-
ried out on 12 crossbred gilts (Large White x Landrace), aged 7-8
months and weighting 90-100 kg, with two controlled subsequent
estrous cycles, that were randomly divided into the control (CON,
n=6) and experimental groups (DXM, n=6). Behavioural estrous
was detected by using the boar-tester. The animals were individu-
ally housed in stalls, under conditions of natural light and room
temperature. They were fed a commercial grain mixture and tap
water ad libitum. All experimental procedures followed the princi-
ples of the animal care (NIH publication No. 86-23, revised in
1985), as well as the specific national law on animal protection. 
In the DXM group, cysts were induced in all animals by i.m.
injections of DXM (3.3 μg/kg of b.w., in total volume of 6 ml;
Dexasone®, Norbrook Laboratory, Newry, UK), every 12 hours
from day 7 (1 day of the study) to day 21 of the first studied estrous
cycle (i.e. by 15 consecutive days). During the same period of
time, animals of the CON group were injected with 6 ml of saline.
The gilts were slaughtered by electrical shock (ENZ 300
Metalowiec, Bydgoszcz, Poland) and exsanguinated on expected
11 day of the second studied estrous cycle (i.e. on 26 day of the
study), and the ovaries were collected. Afterwards, the weight, vol-
ume, length, width and height of the gonads were studied, and the
number of ovarian structures was estimated. The follicles were
divided into two size classes: 1-3 and 4-6 mm in diameter. Follic-
ular structures exceeding 1.0 cm in diameter were classified as
cysts [13]. Samples of follicular and cystic walls and corpora lutea
(CL) were shock-frozen in liquid nitrogen and stored at -80 °C in
order to estimate the expression of P450scc, 3β-HSD and P450arom.
To determine the localization of above-mentioned enzymes by rou-
tine single-immunofluorescence technique, fragments of ovaries
were fixed by immersion in Zamboni`s fixative for 30 min, washed
in 0.1 M phosphate buffer and then stored in 18% sucrose and then
frozen (-80°C) until sectioning.
Western blotting analysis. The P450scc, 3β-HSD and P450arom
protein expression in the ovarian structures was estimated with the
method described by Jana et al. [14]. Briefly, pieces of follicular
and cystic walls, as well as CL (only from animals belonging to the
CON group) were placed in freshly prepared ice-cold homoge-
nization buffer (50 mmol/l Tris-HCl, pH 7,4; 150 mmol/l NaCl;
1% Triton X-100, 1.5 μM/ml aprotinin, 52 μmol/l leupeptin, 1
mmol/l pepstatin A, 1 mmol/l EDTA, 1 mol/l PMSF) and fogged
for 10 min at 2500 × g at 4°C. Homogenates were then centrifuged
for 1 h at 17 500 × g at 4°C and the pellets was stored at -80°C for
further analysis. The protein levels were determined by the method
of Bradford [15]. The equal amounts (20 μg) of membrane frac-
tions were dissolved in sodium dodecyl sulphate (SDS) gel-load-
ing buffer (50 mmol/l Tris-HCl, pH 6.8; 4% SDS, 20% glycerol
and 2% 2-mercaptoethanol), heated to 95°C for 4 min and separat-
ed on 10% SDS-polyacrylamide gel by electrophoresis. Separated
proteins were then electroblotted onto 0.45 μm nitrocellulose
membrane in transfer buffer (20 mmol/l Tris, pH 8.3; 150 mmol/l
glycine, 10% methanol). The nonspecific binding sites were
blocked by shaking with 5% skim milk for 1.5 h at room tempera-
ture (RT). Next, nitrocellulose membrane were incubated
overnight at 4 °C with the primary antibodies including rabbit anti-
rat P450scc polyclonal antibody (diluted 1:1 000; Chemicon,
Temecula, CA, USA), rabbit anti-mouse 3β-HSD polyclonal anti-
body (diluted 1:5 000; a gift from Dr. N. Rahman, University of
Helsinki, Finland) and rabbit anti-human placental P450arom poly-
clonal antibody (diluted 1:2 000; provided by Hauptman-Wood-
ward Medical Research Institute, Inc., Buffalo, USA), and then
with secondary biotinylated goat anti-rabbit antibody (1:3 000;
Vectastain ABC kit; Vector Laboratories, Inc., Burlingame, CA,
USA). Reaction product was visualized by incubation with a mix-
ture of 3,3'-diaminobenzidine tetrahydrochloride (DAB, Sigma-
Aldrich Co., USA) and H2O2 in Tris-buffered saline (pH 7.2) for 3
min. The content of the studied enzyme was determined in each tis-
sue during three independent analyses. All immunoblotts were
quantitated by scanning on KODAK 1D Image Analysis software
(USA). The intensity of bands detected by one-dimensional image
analysis was reported as arbitrary units. Data were expressed as a
ratio of P450scc, 3β-HSD and P450arom proteins relative to β-actin
protein in arbitrary optical density units.
Single-labelling immunofluorescence. Fragments of the ovaries
were cut in a cryostat (Reichert-Jung, Nuβloch, Germany) into 10-
µm-thick sections and then subjected to routine single-immunoflu-
orescence technique described by Coons [16]. Briefly, sections
were incubated in the humid chamber, overnight at RT with anti-
bodies, the same as in Western blotting analyses: rabbit anti-rat
P450scc (diluted 1:500), rabbit anti-mouse 3β-HSD (diluted 1:500)
and rabbit anti-human placental P450arom (diluted 1:500). Primary
antisera were then labelled by species-specific secondary antibod-
ies conjugated to biotin (donkey anti-rat, diluted 1:800) and the lat-
ter antisera were then visualized by a streptavidin-CY3 complex
(diluted 1:9 000), both from Jackson Immunoresearch, USA.
Microscopically, follicles were classified according to develop-
mental stages as primordial, primary, secondary and tertiary
[17,18]. Additionally, tertiary follicles were divided into two size
classes: small (to 3 mm in diameter) and medium (4-6 mm in diam-
eter). The diameter of follicles and cysts, as well as the kind of
ovarian cells displaying immunoreactivity (IR) for studied
enzymes and the intensity of the immunostaining were estimated
using Olympus BX51 microscope equipped with epi-fluorescence
258 A. Koz³owska et al.
©Polish Histochemical et Cytochemical Society
Folia Histochem Cytobiol. 2009:47(2): 258 (257-264) 
doi: 10.2478/v10042-009-0043-x
and appropriate filter sets, as well as a image analysis software
(Olympus Microimage) by two independent researches. The results
were expressed semi-quantitatively (arbitrary) as strong (+++),
high (++), faint (+) or no reactions (-), as described previously by
Levanti et al. [19]. This procedure was applied to 16 randomly
chosen ovarian sections from each of the animal studied and then
pooled and presented as mean value.
Statistical analysis. Student t-test was used to compare the mean
(±SEM) number of the ovarian structures, weight, volume, meas-
urements of ovaries, as well as the intensity of bands staining (arbi-
trary units) between the CON and DXM group (InStat GraphPad,
San Diego, CA).
Results
Macroscopic evaluation of ovaries 
After injections of the DXM, it has been found that the
weight (P<0.01), length (P<0.05) and height (P<0.01)
of the gonads decreased, when compared to the values
observed in control ovaries (Table 1). DXM-induced
cysts, 1-2 cm in diameter, were found in both ovaries
of all the DXM-treated gilts, in mean number of
7.0±1.2 per ovary. Moreover, in the cystic-changed
ovaries the number of small follicles (1-3 mm in diam-
eter) was lower (P<0.05) than in the control animals.
Furthermore, the medium follicles (4-6 mm in diame-
ter) and CL were not present in the ovaries of gilts
treated with DXM. 
P450scc, 3β-HSD and P450arom protein
expression in ovarian structures
Expression of P450scc, 3β-HSD and P450arom proteins
was observed at clearly detectable levels in the folli-
cles and CL of the control gilts and in the follicles and
cysts of the DXM-injected gilts. Expression of P450scc
protein in the walls of small follicles collected from
the DXM group was higher (P<0.05) than in the CON
group. The P450scc (P<0.01), 3β-HSD (P<0.05) and
P450arom (P<0.001) protein levels in the cystic walls
were enhanced compared with the medium follicles of
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Table 1. Mean ( SEM) weight, volume and measurements of the
ovaries, as well as the number of the structural elements in the con-
trol gilts (group CON) and animals after DXM injections (group
DXM).
*p<0.05; **p<0.01 indicate significant differences between the examined
groups, l.s. – the lack of structure
Fig. 1. Western blot of P450scc (I), 3β-HSD (II) and P450arom (III)
A/ in the follicles (F), corpora lutea (CL) of the control gilts (group
CON) and in the F and cysts (C) animals after DXM injections
(group DXM). Group CON, the 1-3 mm F (line 1), the 4-6 mm F
(line 2) and the CL (line 3). Group DXM, the 1-3 mm F (line 4)
and the C (line 5). B/ densitometric analysis of enzymes. Data
were expressed as a ratio of P450scc, 3β-HSD and P450arom pro-
teins relative to β-actin protein in arbitrary optical density units.
*p<0.05; **p<0.01; ***p<0.001 – indicate significant differences
between the examined groups.
the CON group. The expression of 3β-HSD and
P450arom and proteins in the walls of small-sized folli-
cles was similar in both the CON and DXM groups
(Fig. 1).
Localization of P450scc, 3β-HSD and P450arom
in the ovarian structures
Preantral follicles 
The intensity of the immunoreactivity for P450scc in the
follicular cells of primordial follicles in the CON group
was high (Fig. 1A), while faint in the DXM group (Fig.
2B). The granulosa cells in primary follicles in both
studied groups and in the secondary follicles of the
CON group were P450scc-immunonegative, but the
granulosa cells in secondary follicles of the DXM-treat-
ed gilts displayed faint P450scc staining. In turn, positive
reaction for P450arom was not observed in the cells of
primordial, primary and secondary follicles in both
studied groups. These follicles in the CON group were
also 3β-HSD-immunonegative, while in the DXM-
treated gilts displayed faint 3β-HSD staining.
Antral follicles 
P450scc. The granulosa cells of tertiary follicles meas-
uring up to 3 mm in diameter showed faint P450scc
reaction in the CON group, but staining of these cells
was absent in the DXM-treated gonads. In contrast, the
intensity of the immunoreaction for this enzyme in the
theca interna cells of tertiary follicles measuring up to
3 mm in diameter of the control animals was high and
strong in the DXM group. The granulosa and theca
interna cells (Fig. 2C) of tertiary follicles measuring 4-
6 mm in diameter in the CON group showed faint and
high reactivity for P450scc, respectively. In the cysts,
this enzyme staining was high in the granulosa cells
and strong in the theca interna cells (Fig. 2D). 
3β-HSD. In both examined group, the granulosa cells
of tertiary follicles measuring up to 3 mm in diameter
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Fig. 2. Localization of P450scc, 3β-HSD and P450arom in the ovaries of the control gilts (group CON) and animals after DXM injections
(group DXM). High intensity of reaction for P450scc in the follicular cells of primordial follicle in the CON group (A), and faint in DXM
group (B). Faint and high P450scc immunoexpression visible in the granulosa and theca interna cells of tertiary follicle 4-6 mm in diam-
eter of the control gilt, respectively (C), and high in the granulosa and strong in the theca interna layers of cyst (D). Absent of 3 -HSD
in the granulosa cells of secondary follicle in the control gilt (E) and faint staining of these cells in the DXM group (F). No immunos-
taining of 3β-HSD in the granulosa cells of tertiary follicle 4-6 mm in diameter of the control animal (G). High reaction for this enzyme
visible in the granulosa cells of cyst (H). Faint P450arom staining of the granulosa and theca interna cells in tertiary follicle to 3 mm in
diameter of the control gilt (I). High and faint intensity of the reaction in the granulosa and theca interna cells of this follicle in the cys-
tic ovary, respectively (J). High P450arom staining of the granulosa cells in tertiary follicle 4-6 mm in diameter of the control gilt (K).
Note strong intensity of the reaction in the granulosa layer of the cyst (L). PF – primordial follicle, SF – secondary follicle, TF < 3 – ter-
tiary follicle to 3 mm in diameter, TF 4-6 – tertiary follicle 4-6 mm in diameter, C – cyst, GC – granulosa cells, TIC – theca interna cells,
×200.
were 3β-HSD-immunonegative, while the theca inter-
na cells of these follicles were faintly stained. Similar
results were found in tertiary follicles measuring 4-6
mm in diameter in the CON group. The granulosa and
theca interna layers of cyst showed high (Fig. 2H) and
faint immunoractivity for 3β-HSD, respectively. 
P450arom. The granulosa and theca interna cells of ter-
tiary follicles measuring up to 3 mm in diameter in the
CON group were faintly stained for P450arom (Fig. 2I).
In the DXM group, the granulosa and theca interna
cells in these follicles displayed high and faint
P450arom expression (Fig. 2J), respectively. Similar
intensity of the reaction displayed the granulosa (Fig.
2K) and theca interna cells of tertiary follicles meas-
uring 4-6 mm in diameter in the CON group. The
P450arom staining in the granulosa (Fig. 2L) and theca
interna layers of cyst was strong. 
Corpora lutea
In the steroidogenic cells of CL in the CON group, the
intensity of immunoreactivity for P450scc was strong,
while it was faint for 3β-HSD and P450arom.
Discussion
The present study provides the detailed description of
the expression patterns of P450scc, 3β-HSD and
P450arom proteins in the porcine cystic ovaries. Macro-
scopic examination of the ovaries, conducted on day
26 of the study (expected 11 day of the second studied
cycle), revealed that i.m. DXM injections on days 7-21
of the first estrous cycle in the gilts lead to develop-
ment of cystic status of the ovaries. The weight, length
and height of the pathologically changed ovaries were
diminished, what may results from the presence of par-
tially luteinized follicular cysts, the reduction in the
number of small ovarian follicles (1-3 mm in diameter)
and a total lack of both the medium-sized follicles and
CL. Similar results were previously found in the pigs
after adrenocorticotropic hormone (ACTH) or DXM
treatment [9,11,20,21]. 
In the present study, administration of DXM result-
ed in an increase in the level of P450scc and 3β-HSD
protein in the walls of cysts, and P450scc also in the
walls of small-sized follicles. These observations are
in the line with results of our earlier experiment, in
which the ovaries were collected on day 20 of the sec-
ond studied cycle from DXM-treated gilts, receiving
this hormone from day 16 of the first studied estrous
cycle until day 9 of the second studied cycle [9]. More-
over, in the present study we have found that the
expression of P450arom proteins in the cyst walls
increased, while the level of this enzyme, as well as of
3β-HSD did not change significantly in the small fol-
licles in the DXM group. These results, however, dif-
fer from these found in cystic ovaries obtained on day
20 of the second studied cycle from gilts receiving
DXM earlier [9]. These differences may be attributable
to the phase of the estrous cycle, in which the admin-
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Table 2. Localization and intensity of reaction for P450scc, 3β-HSD and P450arom in the ovaries of control gilts (group CON) and animals
after DXM injections (group DXM).
(-) – the lack of staining , + – faint, ++ – high, +++ – strong; l.s. – the lack of structure
istration of cyst-induced DXM was started and can
also result from day of the estrous cycle when the
ovaries were collected.
It is difficult to explain why the expression of
P450scc, 3β-HSD and P450arom proteins increases in
the structures (cysts and/or small follicles) of cystic
ovaries. It is however possible to speculate that
changes in the expression of these enzymes may be a
consequence of the action of (largely unknown) intrag-
onadal factors. One of possible factors leading to an
increase in P450scc and 3β-HSD expression in the cysts
and/or small follicles found in DXM-treated gonads
could be a marked increase in the neuronal input to
these structures. It has namely been found that the
number of dopamine-β-hydroxylase and/or neuropep-
tide tyrosine (NPY) immunoreactive (IR) or vasoac-
tive intestinal polypeptide (VIP)-IR nerve fibers was
distinctly higher in the vicinity of these structures.
Moreover, a simultaneous increase in the amount of
noradrenaline (NA), adrenaline and P4 in wall of these
structures was also stated (unpublished data). Similar
phenomenon has previously been observed by us in the
cystic porcine ovaries [9]. It had been previously
reported that NA stimulated P450scc and 3β-HSD
activity in bovine luteal cells [22] while VIP induced
the synthesis of the P450scc complex in rat granulosa
cells [23]. In turn, there is a lack of data concerning the
effect of neurotransmitter on the expression of
P450arom in the ovarian structures. It was only earlier
found that VIP is able to enhance P450arom activity
[24] and the level of the mRNA encoding this enzyme
in rat granulosa cells [25]. However, the increased
expression of P450scc, observed in the structures of the
cystic ovaries may also be a consequence of the DXM
treatment. This assumption is supported by Yang et al.
[26], who have presented that DXM increased follicle-
stimulating hormone-stimulated P450scc mRNA level
in the porcine granulosa cells. However, there is a lack
of data dealing with the influence of glucocorticoids
on 3β-HSD and P450arom expression in ovarian cells.
Up to now it was only reported that the activity of
P450arom in granulosa cells is suppressed by DXM and
ACTH [21,27]. 
Light-microscopic observation showed that the cel-
lular localization of P450scc, 3β-HSD and P450arom in
steroidogenic cells of follicles and CL in the control
group is in agreement with results of previous studies
performed on ovaries of gilts and goats, with exception
of the presence of P450arom in cells of CL [28-33]. In
turn, the distribution of studied enzymes in the struc-
tures of cystic ovaries has changed. After DXM treat-
ment, faint P450scc-immunoreactivity was visible in
the cells of secondary follicles and for 3β-HSD in the
primordial, primary and secondary follicles, while
labelling for these enzymes was absent from control
gonads. The explanation of this phenomenon is diffi-
cult because in the available literature, there is a com-
plete lack of data concerning the expression of the
examined enzymes in the preantral follicles in cystic
ovaries. As it was mentioned above, the occurrence of
P450scc and 3β-HSD in the follicles of the cystic
gonads may be the result of DXM treatment [26].
Moreover, the presence of numerous nerve fibers con-
taining NPY, vesicular acetylcholine transporter and/or
neuronal nitric oxide synthase (unpublished data)
around the secondary follicles allow to suppose that
NPY, acetylcholine and nitric oxide may also effect the
expression of P450scc and 3β-HSD in these follicles. In
contrast, the decrease in the intensity of P450scc stain-
ing, in the primordial follicles, as well as the lack of
this enzyme in granulosa cells of follicles with the
diameter up to 3 mm, observed in the DXM-treated
gilts, could be probably a consequence of derangement
in maturation of these follicles evoked by DXM [34].
Thus, appearance of P450scc and 3β-HSD proteins in
preantral follicles of the cystic ovaries may suggest
steroidogenic activity of these structures.
Furthermore, we also found the presence of 3β-
HSD in granulosa layers of the cysts, while the
immunoreactivity of this enzyme was absent in gran-
ulosa cells of medium follicles in the control ovaries.
However, the 3β-HSD staining in theca interna cells
of cysts and above-mentioned follicles was similar.
These results are in agreement with findings of
Calder et al. [35] who reported 3β-HSD mRNA
expression in the bovine granulosa and theca interna
layers of cysts. However, Kaaijk et al. [6] have shown
the presence of 3β-HSD only in the follicular theca
interna cells of polycystic ovaries of women. Most
probably, the presence of 3β-HSD-immunoreactivity
in the granulosa layer of cysts may be the consequence
of the luteinization of granulosa cells, what has previ-
ously been suggested in women with the polycystic
ovary syndrome [36]. Moreover, in our experiment the
granulosa and theca interna layers of cysts demon-
strated P450scc and P450arom staining, which was sig-
nificantly higher than in the follicles 4-6 mm in diam-
eter of control animals. The positive reaction for
P450scc and P450arom was also observed in both gran-
ulosa and theca interna layers of small follicles (with
exception of the presence of P450scc in granulosa cells
of the CON group) in all animals, but the intensity of
immunolabelling to P450scc in theca interna cells, and
to P450arom in granulosa cells was stronger after DXM
treatment. Similar localization of P450scc was
described earlier in the follicular structures from poly-
cystic ovaries of women [6], whereas in cows the
P450scc reaction was presented only in the theca inter-
na cells of cysts [8]. However, the higher intensity of
the immunoreaction for P450scc in the theca interna
layer of cysts and follicles is in line with Jakimiuk et
al. [36] earlier study where they have found an
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increase in the P450scc mRNA expression in the theca
interna cells of follicles in the women with COD.
Appearance of 3β-HSD protein in the granulosa layer
of the cysts, observed in the present study after DXM
injections, as well as the increased intensity of the
labelling towards P450scc in the two theca layers of
cysts and theca interna cells of follicles measuring up
to 3 mm in diameter, suggest that an up-regulated syn-
thesis of P4 may take place in these cells. On the other
hand, the observed increase in the immunoexpression
of P450arom in the theca interna cells (with exception
of the presence of P450arom in theca interna cells of
small follicles in the DXM group) and also in the gran-
ulosa layer of above-listed structures, suggest a simul-
taneous up-regulation in the production of estrogen in
the cystic ovaries.
In conclusion, the present study clearly show that in
porcine ovaries with polycystic status, induced by
DXM injections on days 7-21 of the estrous cycle, the
expression and localization patterns of P450scc, 3β-
HSD and P450arom were changed. Moreover, these
results may suggest also that these enzymes, trough the
control of ovarian steroidogenesis, may play an essen-
tial role in the formation and/or course of cystic ovar-
ian disease. 
Acknowledgements: We would like to thank Dr. N. Rahman from
University of Helsinki, Finland, for his kind donation of 3β-HSD
antibodies. This work was supported by grant no. 3PO6K00722
from the State Committee for Scientific Research in Poland. 
References
[ 1] Scholten JA, Liptrap RM. A role for the adrenal cortex in the
onset of cystic ovarian follicles in the sow. Can J Comp Med.
1978;42:525-533.
[ 2] Elliot JI, King GJ, Robinson HA. Reproductive performance
of the sow subsequent to weaning piglets at birth. Can J
Comp Med. 1980;60:65-71.
[ 3] Stoebel DP, Moberg GP. Repeated acute stress during the fol-
licular phase and luteinizing hormone surge of dairy heifers.
J Dairy Sci. 1982;65:92-96. 
[ 4] Boryczko Z, Bostedt H, Hoffmann B. Comparison of the hor-
monal and chemical composition of the fluid from bovine
ovarian follicles and cysts. Reprod Domest Anim. 1995;30:36-
38.
[ 5] Takayama K, Fukaya T, Sasano H, et al. Immunohistochemi-
cal study of steroidogenesis and cell proliferation in polycys-
tic ovarian syndrome. Hum Reprod. 1996;11:1387-1392.
[ 6] Kaaijk EM, Sasano H, Suzuki T, Beek JF, van Der Veen F.
Distribution of steroidogenic enzymes involved in androgen
synthesis in polycystic ovaries: an immunohistochemical
study. Mol Hum Reprod. 2000;6:443-447.
[7] Cooke GM, Brawer JR, Farookhi R. Steroidogenic enzyme
activities in rat polycystic ovaries. Can J Physiol Pharmacol.
1993;71:247-253.
[ 8] Isobe N, Nakao T, Yoshimura Y. Distribution of cytochrome
P450-side chain cleavage in the theca interna layers of bovine
small antral and cystic follicles. Reprod Domest Anim. 2003;
38:405-409.
[ 9] Jana B, Dzienis A, Rogoziñska A, et al. Dexamethasone-
induced changes in sympathetic innervation of porcine
ovaries and in their steroidogenic activity. J Reprod Dev.
2005;6:715-725.
[10] Peter AT, Liptrap RM. Plasma gonadotrophin levels in sows
with experimental cystic ovarian follicles. British Vet J. 1985;
141:288-296.
[11] Frautschy SA, Liptrap RM. Anovulation and plasma hormone
concentrations after administration of dexamethasone during
the middle of the luteal phase in sows undergoing estrous
cycles. Am J Vet Res. 1988;49:1270-1275.
[12] Cook DL, Smith CA Parfet JR, Youngquist RS, Brown EM,
Garverick HA. Fate and turnover rate of ovarian follicular
cysts in dairy cattle. J Reprod Fertil. 1990;90:37-46.
[13] Nalbandov AV. Anatomic and endocrine causes of sterility in
female swine. Fertil Steril. 1952;3:100-114.
[14] Jana B, Koz³owska A, Andronowska A, Jedliñska-Krakowska
M. The effect of tumor necrosis factor-β (TNF-β), interleukin
(IL)-1  and IL-6 on chorioamnion secretion of prostaglandins
(PG)F2β and E2 in pigs. Rep Biol. 2008;8:57-68.
[15] Bradford MM. A rapid and sensitive method for the quantita-
tion of microgram quantities of protein utilizing the principle
of protein-dye binding. Anal Biochem. 1976,72:248-254.
[16] Coons AH. Fluorescent antibody methods. General Cytochem
Methods. 1958;1:399-422.
[17] Greenwald GS, Moor RM. Isolation and preliminary charac-
terization of pig primordial follicles. J Reprod Fertil. 1989;
87:561-571.
[18] Wulff C, Wilson H, Wiegand SJ, Rudge JS, Fraser HM.
Prevention of thecal angiogenesis, antral follicular growth,
and ovulation in the primate by treatment with vascular
endothelial growth factor trap R1R2. Endocrinology. 2002;
143:2797-2807.
[19] Levanti MB, GermanαA, Abbate F, Montalbano G, Vega JA,
Germanα G. TrkA and p75NTR in the ovary of adult cow and
pig. J Anat. 2005;207:93-96.
[20] Ogasa A, Domeki I, Itoh S, Tsutsui T, Kawakami E. The for-
mation of cystic ovarian follicles in the sows after treatment
with ACTH. Jpn J Zootech Sci. 1988;59:1004-1012.
[21] Ryan PL, Raeside JI. Steroidogenesis in granulosa cells after
the induction of large cystic follicles with adrenocorty-
cotropin (ACTH) in the cyclic gilt. In: Proceedings of 11th
International Congress on Animal Reproduction and Artificial
Insemination Dublin Ireland, Abstract, 1988;458.
[22] Kotwica J, Bogacki M, Rêkawiecki R. Neural regulation of
the bovine corpus luteum. Domest Anim Endocrinol. 2002;
23:299-308.
[23] Trzeciak WH, Ahmed CE, Simpson ER, Ojeda SR. Vasoactive
intestinal peptide induces the synthesis of the cholesterol
side-chain cleavage enzyme complex in cultures rat ovarian
granulosa cells. Proc Natl Acad Sci. 1986;83:7490-7494.
[24] George FW, Ojeda SR. Vasoactive intestinal peptide enhances
aromatase activity in the neonatal rat ovary before develop-
ment of primary follicles or responsiveness to follicle stimu-
lating hormone. Proc Natal Acad Sci. 1987;84:5803-5807.
[25] Mayerhofer A, Dissen GA, Costa ME, Ojeda SR. A role for
neurotransmiters in early follicular development: induction of
functional follicle-stimulating hormone receptors in newly
formed follicles of the rat ovary. Endocrinology. 1997;138:
3320-3329.
[26] Yang JG, Yu CC, Li PS. Dexamethasone enhances follicle
stimulating hormone-induced P450scc mRNA expression and
progesterone production in pig granulosa cells. Chinese J
Physiol. 2001;44:111-119.
[27] Kawate N, Inaba T, Mori J. Changes in plasma concentrations
of gonadotropins and steroid hormones during the formation
of bovine cysts induced by the administration of ACTH. J Vet
Med Sci. 1996;58:141-144.
[28] Lautincik J, Kolodzieyski L, Elias V, Hyttel P, Osawa Y,
Sirotkin A. Immunocytochemical localization of aromatase in
263Dystrybution of steroidogenic enzymes in the cystic porcine ovaries
©Polish Histochemical et Cytochemical Society
Folia Histochem Cytobiol. 2009:47(2): 263 (257-264) 
doi: 10.2478/v10042-009-0043-x
the ovary of superovulated cattle, pigs and sheep. Acta Vet
Scand.1994;35:185-191.
[29] Conley AJ, Kaminski MA, Dubowsky SA, Jablonka-Shariff
A, Redmer DA, Reynolds LP. Immunohistochemical local-
ization of 3 beta-hydroxysteroid dehydrogenase and P450 17
alpha-hydroxylase during follicular and luteal development in
pigs, sheep and cows. Biol Reprod. 1995;52:1081-1094.
[30] Garrett WM, Guthire HD. Steroidogenic enzyme expression
during preovulatory follicle maturation in pigs. Biol Reprod.
1996;56:1424-1431.
[31] Shores E, Picton HM, Harada N, Hunter MG. Immunohisto-
chemical localization of steroidogenic enzymes within the
porcine follicles. Raport of NOW'97, 1997.
[32] S³omczynska M, Tabarowski Z. Localization of androgen
receptor and cytochrome P450 aromatase in the follicle and
corpus luteum of the porcine ovary. Anim Reprod Sci. 2001;
65:127-134.
[33] Weng Q, Medan MS, Ren L, Watanabe G, Tsubota T, Taya, K.
Immunolocalization of steroidogenic enzymes in the corpus
luteum and placenta of the Japanese Shiba goat. J Reprod
Dev. 2005;51:247-252.
[34] Gee CM; Geissinger HD, Liptrap RM. Morphometric and
steroid hormone changes associated with experimental
anovulatory follicles in the sow. Can J Vet Res. 1991;55:206-
211.
[35] Calder MD, Manikkam M, Salfen BE, et al. Dominant bovine
ovarian follicular cysts express increased levels of messenger
RNAs for luteinizing hormone receptor and 3 beta-hydroxys-
teroid dehydrogenase delta (4), delta (5) isomerase compared
to normal dominant follicles. Biol Reprod. 2001;65:471-476.
[36] Jakimiuk AJ, Weitsman SR, Navab A, Magoffin DA. Luteiniz-
ing hormone receptor, steroidogenesis acute regulatory pro-
tein, and steroidogenic enzyme messenger ribonucleic acids
are overexpressed in thecal and granulosa cells from poly-
cystic ovaries. J Clin Endocrinol Metab. 2001;86:1318-1323.
Submitted: 8 February, 2009
Accepted after reviews: 13 March, 2009
264 A. Koz³owska et al.
©Polish Histochemical et Cytochemical Society
Folia Histochem Cytobiol. 2009:47(2): 264 (257-264) 
doi: 10.2478/v10042-009-0043-x
